Durham, NC – Enrique Soto Pérez de Celis, M.D., Ph.D., was awarded The Oncologist’s 4th Annual Young Investigator Award for his research on improving access to supportive and palliative care for cancer patients in low- and middle-income countries. The Oncologist journal established this award to foster advancements in the field of oncology by honoring a young researcher who is principal author of a high-impact article with the greatest potential to improve patient outcomes.
In his winning paper, Dr. Soto and his team found that patient navigation systems, supported by a multidisciplinary team, allow institutions to utilize existing resources in a better and more efficient way when treating patients with advanced cancer. They also found that patient navigation led to an increase in advance care planning and on the completion of advance directives, and that it significantly reduced moderate to severe pain at three-month follow-up.
Credit: AlphaMed Press
Durham, NC – Enrique Soto Pérez de Celis, M.D., Ph.D., was awarded The Oncologist’s 4th Annual Young Investigator Award for his research on improving access to supportive and palliative care for cancer patients in low- and middle-income countries. The Oncologist journal established this award to foster advancements in the field of oncology by honoring a young researcher who is principal author of a high-impact article with the greatest potential to improve patient outcomes.
In his winning paper, Dr. Soto and his team found that patient navigation systems, supported by a multidisciplinary team, allow institutions to utilize existing resources in a better and more efficient way when treating patients with advanced cancer. They also found that patient navigation led to an increase in advance care planning and on the completion of advance directives, and that it significantly reduced moderate to severe pain at three-month follow-up.
Dr. Soto’s work has led to the implementation of a patient navigation system at his own institution. He hopes to one day establish a network of trained medical navigators working on behalf of cancer patients across Mexico and worldwide.
Dr. Soto is currently a researcher in medical sciences in the Department of Geriatrics at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, a public academic hospital located in southern Mexico City that provides care for uninsured patients. He also leads its multidisciplinary Geriatric Oncology Clinic.
“The editors of the journal are very pleased to honor Dr. Soto for his exemplary work in bringing patient navigation to the problem of improving cancer care in low- and middle-income countries. His work addresses a fundamental gap in connecting patients to health care systems, a problem of overriding importance in this setting,” said Bruce A. Chabner, M.D., Editor-in-Chief of The Oncologist.
Learn more about Dr. Soto or read the winning paper Patient Navigation to Improve Early Access to Supportive Care for Patients with Advanced Cancer in Resource-Limited Settings: A Randomized Controlled Trial.
###
About The Oncologist: Now in its 26th year, this internationally peer-reviewed journal focuses on clear and concise interpretation addressing the multimodality diagnosis, treatment, and quality of life of the cancer patient. Each issue is meant to impact the practice of oncology and to facilitate significant communication in the introduction of new medical treatments and technologies. The Oncologist is the official journal of the Society for Translational Oncology (STO).
About AlphaMed Press: Established in 1983, AlphaMed Press, with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes three internationally renowned peer-reviewed journals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines. The Oncologist® (www.TheOncologist.com) is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. STEM CELLS® (www.StemCells.com) is the world’s first journal devoted to this fast-paced field of research. STEM CELLS Translational Medicine® (SCTM; www.StemCellsTM.com) is dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.
About Wiley: Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical and scholarly journals, combined with our digital learning, assessment and certification solutions, help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company’s website can be accessed at www.wiley.com.
